Potency of positive γ-aminobutyric acidA modulators to substitute for a midazolam discriminative stimulus in untreated monkeys does not predict potency to attenuate a flumazenil discriminative stimulus in diazepam-treated monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 3, 2001, Pages 1227-1235

  Mcmahon, Lance R ^a   Gerak, Lisa R ^b   France, Charles P ^a,c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; AMOBARBITAL; BENZODIAZEPINE; DIAZEPAM; FLUMAZENIL; MIDAZOLAM; PENTOBARBITAL; PREGNENOLONE; TRIAZOLAM; ZALEPLON; ZOLPIDEM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG CROSS TOLERANCE; DRUG SPECIFICITY; DRUG TOLERANCE; DRUG WITHDRAWAL; FEMALE; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; DIAZEPAM; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUMAZENIL; GABA MODULATORS; HYPNOTICS AND SEDATIVES; MACACA MULATTA; MALE; MIDAZOLAM; RECEPTORS, GABA-A; STEROIDS;

EID: 0034883055     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. A receptor needs two homologous domains of the β-subunit for activation by GABA but not by pentobarbital
2. Zaleplon and triazolam: Drug discrimination, plasma levels, and self-administration in baboons
3. Selectivity in the generalization profile in baboons trained to discriminate lorazepam: Benzodiazepines, barbiturates, and other sedative/hypnotics
4. A review of the preclinical development of zaleplon, a novel non-benzodiazepine hypnotic for the treatment of insomnia
5. A receptor subtypes differentiated by their γ-subunit variants: Prevalence, pharmacology and subunit architecture
6. Tolerance to suppressive effects of chlordiazepoxide on operant behavior: Lack of cross tolerance to pentobarbital
7. Zolpidem, a novel non benzodiazepine hypnotic. I. Neuropharmacological and behavioral effects
8. Tolerance to the behavioral actions of benzediazepines
9. Repeated administration of flumazenil does not alter its potency in modifying schedule-controlled behavior in chlordiazepoxidetreated rhesus monkeys
10. Discriminative stimulus effects of flumazenil in untreated and in diazepam-treated rhesus monkeys
11. Zolpidem behavioral pharmacology in baboons: Self-injection, discrimination, tolerance and withdrawal
12. A subunit mRNA in rat brain
13. Ro 15-1788 antagonizes the discriminative stimulus effects of diazepam in rats but not similar effects of pentobarbital
14. Chronic benzodiazepine agonist treatment produces functional uncoupling of the γ-aminobutyric acid-benzodiazepine receptor ionophore complex in cortical neurons
15. A/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach
16. Discriminative stimulus effects of triazolam and midazolam in rhesus monkeys
17. A modulators in rhesus monkeys discriminating midazolam
18. Using behavior to elucidate receptor mechanisms: A review of the discriminative stimulus effects of benzodiazepines
19. A receptor selective for a behavioural alcohol antagonist
20. Precipitated diazepam withdrawal in baboons: Effects of dose and duration of diazepam exposure
21. 1 subtype
22. A receptors
23. A receptor subunit composition?
24. A receptors
25. Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself
26. Benzodiazepine-specific and nonspecific tolerance following chronic flurazepam treatment
27. Discriminative stimulus effects of zolpidem in squirrel monkeys: Comparison with conventional benzodiazepines and sedative-hypnotics
28. Zaleplon and triazolam in humans: Acute behavioral effects and abuse potential
29. The effects of new hypnotic drugs in rats trained to discriminate ethanol
30. Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem
31. The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic
32. A receptor subtypes
33. Disruption of schedule-controlled behavior by Ro 15-1788 one day after acute treatment with benzodiazepines
34. Evaluation of the discriminative stimulus effects of the novel sedative-hypnotic CL 284,846
35. 4 subunit
36. Benzodiazepines: Use, abuse, and consequences
37. Discriminative stimulus properties of midazolam: Comparison with other benzodiazepines
38. Dependence liability of several sedative-hypnotic agents evaluated in monkeys